Candriam Equities L Biotech.C USD Acc/ LU0108459040 /
| NAV2024-04-23 | Chg.+10.2400 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 798.8100USD | +1.30% | reinvestment | Equity | Candriam ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 2024-04-25 | Public WebStation Live Factsheet | 2024 | English | - |
| 2024-03-01 | PRIIP Key Information Document | 2024 | German | 268.16 KB |
| 2023-12-31 | Account statment | 2023 | English | 5,416.37 KB |
| 2023-09-11 | Prospectus | 2023 | English | 3,638.77 KB |
| 2023-09-11 | Prospectus | 2023 | German | 3,801.35 KB |
| 2023-09-11 | PRIIP Key Information Document | 2023 | English | 217.63 KB |
| 2023-06-30 | Semi-annual report | 2023 | English | 1,982.78 KB |
| 2023-06-30 | Semi-annual report | 2023 | German | 2,086.39 KB |
| 2022-12-31 | Account statment | 2022 | German | 4,696.56 KB |
| 2022-12-01 | Key Investor Information | 2022 | German | 367.75 KB |
